News that a second baby born with HIV appears to have been cleared of infection after early and aggressive treatment is further evidence that early therapy may be the key to achieving remission, said immunologist Katherine Luzuriaga, MD, who is working on both cases.
The revised nutrition labels proposed by the Food and Drug Administration, featuring prominent calorie counts and more realistic portion sizes, are a welcome change to clinical psychologist Sherry Pagoto, PhD, as she helps teach weight loss patients about healthy eating habits.
UMMS Nobel laureate Craig C. Mello explains how a genome-engineering tool known as Crispr may allow scientists to alter the DNA of humans, animals and plants, a research breakthrough that promises to make a significant impact on science and fighting diseases, according to a March 3 story in the New York Times.
A team of UMass Medical School researchers is developing tools for the classroom and clinic to help teach communications skills to nonverbal children on the autism spectrum who struggle to understand that pictures relate to real-life objects or events.
Jeremy Luban and Trudy Morrison have been elected fellows of the American Academy of Microbiology.
The discovery of RNA interference, the breakthrough that earned UMass Medical School’s Craig C. Mello, PhD, and Stanford University’s Andrew Z. Fire, PhD, the Nobel Prize in Medicine in 2006, is fueling significant progress for some local biotech companies who are using it to fight diseases, according to a story in the Feb. 24 Boston Globe.
Terence R. Flotte, MD, was among a panel of cystic fibrosis experts that provided a congressional briefing on the benefits of the Cystic Fibrosis Foundation’s model of specialized, coordinated care and its innovative strategies for drug development, and how they can serve as an example for other rare, chronic diseases.
UMMS scientists have developed a novel interspecies model system that allows researchers to examine how a single nutrient or vitamin changes gene expression and physiology in the model organism C. elegans, in a study appearing in the journal Cell.
Judson Brewer, MD, PhD, who recently joined the faculty at UMass Medical School as associate professor of medicine and psychiatry and director of research at the Center for Mindfulness, examines brain activity of trial participants practicing “loving kindness” mediation in his lab at Yale University, according to a new paper on the research published in the journal Brain and Behavior.
UMass Medical School recognizes the launch today of Voyager Therapeutics, a gene therapy company founded by four world leaders in the fields of AAV gene therapy, RNA biology and neuroscience, to develop life-changing treatments for fatal and debilitating diseases of the central nervous system.